Nimodipine
Nimodipine Capsules For Oral Use
Approved
Approval ID
18855589-5063-484f-a064-cb1110833302
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 13, 2023
Manufacturers
FDA
McKesson Corporation dba SKY Packaging
DUNS: 140529962
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Nimodipine
PRODUCT DETAILS
NDC Product Code63739-797
Application NumberANDA090103
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 13, 2023
Generic NameNimodipine
INGREDIENTS (8)
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
PEPPERMINT OILInactive
Code: AV092KU4JH
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
NIMODIPINEActive
Quantity: 30 mg in 1 1
Code: 57WA9QZ5WH
Classification: ACTIB